» Articles » PMID: 37513559

Polyunsaturated Fatty Acid Intake During Complementary Feeding and Neurodevelopmental Outcome in Very Low Birth Weight Infants

Overview
Journal Nutrients
Date 2023 Jul 29
PMID 37513559
Authors
Affiliations
Soon will be listed here.
Abstract

Polyunsaturated fatty acids (PUFAs) are vital for brain development, yet limited knowledge exists regarding PUFA intake during complementary feeding (CF) and its impact on neurodevelopmental outcomes in very low birth weight (VLBW) infants. This secondary analysis of a randomized intervention trial, aimed to investigate the association between dietary intake of total PUFAs, arachidonic acid (AA), and docosahexaenoic acid (DHA) during CF and neurodevelopmental outcomes at 12 and 24 months of corrected age (CA). Dietary intakes were assessed using monthly 3 day dietary protocols from 3 to 12 months CA. Neurodevelopmental outcome was evaluated using the Bayley Scales of Infant Development-III. Among the 177 randomized patients, PUFA intake and neurodevelopmental outcomes were evaluated in 140 (79%) infants. Higher total PUFA and DHA intakes significantly correlated with improved cognitive and motor function at 12 months CA, while increased AA intake notably enhanced motor scores at 12 months CA. However, median dietary intakes of AA and DHA (AA: 53.50-84.25 mg/d; DHA: 51.47-76.23 mg/d) fell short of recommended levels (AA: 140 mg/d; DHA: 100 mg/d) at any of the investigated timepoints. These findings emphasize the need to enhance total PUFA, DHA and AA intakes during CF, ensuring adherence to guidelines and unlocking the potential to improve neurodevelopmental outcomes in VLBW infants.

Citing Articles

Lipidomics Analysis Reveals the Effects of Docosahexaenoic Acid from Different Sources on Prefrontal-Cortex Synaptic Plasticity.

He Z, Xiong W, Yang Y, Zhang Y, Li B, Wang F Nutrients. 2025; 17(3).

PMID: 39940315 PMC: 11819862. DOI: 10.3390/nu17030457.


Macronutrient Intake during Complementary Feeding in Very Low Birth Weight Infants Comparing Early and Late Introduction of Solid Foods: A Secondary Outcome Analysis.

Gsoellpointner M, Thanhaeuser M, Kornsteiner-Krenn M, Eibensteiner F, Ristl R, Jilma B Nutrients. 2024; 16(19).

PMID: 39408387 PMC: 11478545. DOI: 10.3390/nu16193422.


Dietary Supplementation with n-3 Polyunsaturated Fatty Acids Delays the Phenotypic Manifestation of Krabbe Disease and Partially Restores Lipid Mediator Production in the Brain-Study in a Mouse Model of the Disease.

Signorini C, Pannuzzo G, Graziano A, Moretti E, Collodel G, Cardile V Int J Mol Sci. 2024; 25(13).

PMID: 39000257 PMC: 11241235. DOI: 10.3390/ijms25137149.


Could early life DHA supplementation benefit neurodevelopment? A systematic review and meta-analysis.

Hu R, Xu J, Hua Y, Li Y, Li J Front Neurol. 2024; 15:1295788.

PMID: 38645744 PMC: 11032049. DOI: 10.3389/fneur.2024.1295788.

References
1.
Smith S, Rouse C . Docosahexaenoic acid and the preterm infant. Matern Health Neonatol Perinatol. 2017; 3:22. PMC: 5725938. DOI: 10.1186/s40748-017-0061-1. View

2.
Heath R, Klevebro S, Wood T . Maternal and Neonatal Polyunsaturated Fatty Acid Intake and Risk of Neurodevelopmental Impairment in Premature Infants. Int J Mol Sci. 2022; 23(2). PMC: 8775484. DOI: 10.3390/ijms23020700. View

3.
Brenna J, Varamini B, Jensen R, Diersen-Schade D, Boettcher J, Arterburn L . Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am J Clin Nutr. 2007; 85(6):1457-64. DOI: 10.1093/ajcn/85.6.1457. View

4.
Dewey K, Beaton G, Fjeld C, Lonnerdal B, Reeds P . Protein requirements of infants and children. Eur J Clin Nutr. 1996; 50 Suppl 1:S119-47; discussion S147-50. View

5.
Fleith M, Clandinin M . Dietary PUFA for preterm and term infants: review of clinical studies. Crit Rev Food Sci Nutr. 2005; 45(3):205-29. DOI: 10.1080/10408690590956378. View